129 related articles for article (PubMed ID: 27255061)
21. Molecular determination of Mycobacterium leprae viability by use of real-time PCR.
Martinez AN; Lahiri R; Pittman TL; Scollard D; Truman R; Moraes MO; Williams DL
J Clin Microbiol; 2009 Jul; 47(7):2124-30. PubMed ID: 19439537
[TBL] [Abstract][Full Text] [Related]
22.
Das M; David D; Horo I; Van Hooij A; Tió-Coma M; Geluk A; Vedithi SC
Front Microbiol; 2023; 14():1113318. PubMed ID: 37051521
[TBL] [Abstract][Full Text] [Related]
23. Role of TEFFECTOR/MEMORY Cells, TBX21 Gene Expression and T-Cell Homing Receptor on Type 1 Reaction in Borderline Lepromatous Leprosy Patients.
Dos Santos LN; da Silva PH; Alvim IM; Nery JA; Lara FA; Sarno EN; Esquenazi D
PLoS One; 2016; 11(10):e0164543. PubMed ID: 27764137
[TBL] [Abstract][Full Text] [Related]
24. Presence of oral lesions in leprosy patients does not imply involvement by Mycobacterium leprae.
Morgado de Abreu MA; Neto Pimentel DR; Morgado de Abreu NM; Watashi Hirata CH; Michalany NS; Maurice Weckx LL; Mota de Avelar Alchorne M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):328-9. PubMed ID: 20056461
[No Abstract] [Full Text] [Related]
25. Changes in the size and number of skin lesions in PB leprosy on treatment and follow-up.
Rao PN; Suneetha S; Pratap DV
Lepr Rev; 2011 Sep; 82(3):244-52. PubMed ID: 22125932
[TBL] [Abstract][Full Text] [Related]
26. Viability of Mycobacterium leprae in skin and peripheral nerves and persistence of nerve destruction in multibacillary patients after 2 years of multidrug therapy.
Job CK; Jayakumar J; Aschhoff M; Mathan MM
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):44-50. PubMed ID: 8627112
[TBL] [Abstract][Full Text] [Related]
27. Use of reverse transcription polymerase chain reaction for the detection of Mycobacterium leprae in the slit-skin smears of leprosy patients.
Jadhav RS; Kamble RR; Shinde VS; Edward S; Edward VK
Indian J Lepr; 2005; 77(2):116-27. PubMed ID: 16044809
[TBL] [Abstract][Full Text] [Related]
28. Gene set signature of reversal reaction type I in leprosy patients.
Orlova M; Cobat A; Huong NT; Ba NN; Van Thuc N; Spencer J; Nédélec Y; Barreiro L; Thai VH; Abel L; Alcaïs A; Schurr E
PLoS Genet; 2013; 9(7):e1003624. PubMed ID: 23874223
[TBL] [Abstract][Full Text] [Related]
29. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
Kamal R; Dayal R; Katoch VM; Katoch K
Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
[TBL] [Abstract][Full Text] [Related]
30. Development and evaluation of real-time RT-PCR assay for quantitative estimation of viable Mycobacterium leprae in clinical samples.
Sharma R; Lavania M; Katoch K; Chauhan DS; Gupta AK; Gupta UD; Yadav VS; Katoch VM
Indian J Lepr; 2008; 80(4):315-21. PubMed ID: 20329380
[TBL] [Abstract][Full Text] [Related]
31. Are viable Mycobacterium leprae present in lepromatous patients after completion of 12 months' and 24 months' multi-drug therapy?
Ebenezer GJ; Daniel S; Norman G; Daniel E; Job CK
Indian J Lepr; 2004; 76(3):199-206. PubMed ID: 15835604
[TBL] [Abstract][Full Text] [Related]
32. Comparison of radiorespirometric Budemeyer assay with ATP assay and mouse foot pad test in detecting viable Mycobacterium leprae from clinical samples.
Agrawal VP; Shetty VP
Indian J Med Microbiol; 2007 Oct; 25(4):358-63. PubMed ID: 18087085
[TBL] [Abstract][Full Text] [Related]
33. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
[TBL] [Abstract][Full Text] [Related]
34. Reverse transcription-PCR detection of Mycobacterium leprae in clinical specimens.
Kurabachew M; Wondimu A; Ryon JJ
J Clin Microbiol; 1998 May; 36(5):1352-6. PubMed ID: 9574704
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Mycobacterium leprae Genotypes in China--Identification of a New Polymorphism C251T in the 16S rRNA Gene.
Yuan Y; Wen Y; You Y; Xing Y; Li H; Weng X; Wu N; Liu S; Zhang S; Zhang W; Zhang Y
PLoS One; 2015; 10(7):e0133268. PubMed ID: 26196543
[TBL] [Abstract][Full Text] [Related]
36. Natural environmental water sources in endemic regions of northeastern Brazil are potential reservoirs of viable Mycobacterium leprae.
Arraes MLBM; Holanda MV; Lima LNGC; Sabadia JAB; Duarte CR; Almeida RLF; Kendall C; Kerr LRS; Frota CC
Mem Inst Oswaldo Cruz; 2017 Dec; 112(12):805-811. PubMed ID: 29211240
[TBL] [Abstract][Full Text] [Related]
37. Is CXCL10/CXCR3 axis overexpression a better indicator of leprosy type 1 reaction than inducible nitric oxide synthase?
Sharma I; Singh A; Mishra AK; Singh LC; Ramesh V; Saxena S
Indian J Med Res; 2015 Dec; 142(6):681-9. PubMed ID: 26831417
[TBL] [Abstract][Full Text] [Related]
38. Mycobacterium leprae DNA in peripheral blood may indicate a bacilli migration route and high-risk for leprosy onset.
Reis EM; Araujo S; Lobato J; Neves AF; Costa AV; Gonçalves MA; Goulart LR; Goulart IM
Clin Microbiol Infect; 2014 May; 20(5):447-52. PubMed ID: 24033793
[TBL] [Abstract][Full Text] [Related]
39. Detection of Mycobacterium leprae DNA in skin lesions of leprosy patients by PCR may be affected by amplicon size.
Goulart IM; Cardoso AM; Santos MS; Gonçalves MA; Pereira JE; Goulart LR
Arch Dermatol Res; 2007 Aug; 299(5-6):267-71. PubMed ID: 17530267
[TBL] [Abstract][Full Text] [Related]
40. Viability determination of M.leprae: comparison of normal mouse foot pad and bacillary ATP bioluminescence assay.
Gupta UD; Katoch K; Natarajan M; Sharma VD; Sharma RK; Shivannavar CT; Katoch VM
Acta Leprol; 1997; 10(4):209-12. PubMed ID: 9447254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
